NCT01966744

Brief Summary

The purpose of the study is to develop, evaluate, and optimize an interactive website (the SMART portal). The SMART portal will use IBD-specific and general assessments and interventions to reduce the burden of common barriers to treatment adherence and enhance self-management skills. This study aims to build and revise the SMART portal according to feedback and testing from participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2013

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 4, 2013

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 22, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

July 19, 2017

Status Verified

July 1, 2017

Enrollment Period

2.9 years

First QC Date

October 4, 2013

Last Update Submit

July 18, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Medication adherence

    Medication adherence will be measured by pill count data provided by patients or caregivers at baseline and post-treatment during Phase 3. Phase 3 will start approximately in October 2014 and continue through March 2015.

    Phase 3 - Approximately 2-6 months, depending upon progression through portal components

Secondary Outcomes (2)

  • Disease severity

    Phase 3 - Approximately 2-6 months, depending upon progression through portal components

  • Health-related quality of life

    Phase 3 - Approximately 2-6 months, depending upon progression through portal components

Study Arms (3)

Clinicians/Nurses

Clinicians and nurses who treat patients diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

Patients

Patients age 11-18 years diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

Caregivers

Caregivers of patients diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients, caregivers, clinicians, and nurses will be recruited from the IBD clinic at Cincinnati Children's Hospital Medical Center.

You may qualify if:

  • Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively known as IBD)
  • Patient between 11 and 18 years of age
  • Patient prescribed at least one oral medication used to treat IBD
  • Access to the internet whether public (example, library) or private (example, home, personal)
  • English fluency for patient, caregiver, and clinician/nurse
  • Clinician/nurse currently providing medical treatment to patients diagnosed with IBD through the IBD Center at Cincinnati Children's Hospital Medical Center

You may not qualify if:

  • Diagnosis of pervasive developmental disorder in patient or caregiver
  • Diagnosis of serious mental illness (example, schizophrenia) in patient or caregiver

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

BeHealth Solutions, LLC

Charlottesville, Virginia, 22901, United States

Location

Related Publications (1)

  • Hommel KA, Ramsey RR, Gray WN, Denson LA. Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 Jan 1;76(1):38-42. doi: 10.1097/MPG.0000000000003623. Epub 2022 Sep 20.

MeSH Terms

Conditions

Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Officials

  • Lee Denson, M.D.

    Children's Hospital Medical Center, Cincinnati

    STUDY CHAIR
  • James Peugh, Ph.D.

    Children's Hospital Medical Center, Cincinnati

    STUDY CHAIR
  • Korey Hood, Ph.D.

    University of California, San Francisco

    STUDY CHAIR
  • Lee Ritterband, Ph.D.

    BeHealth Solutions, LLC.

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2013

First Posted

October 22, 2013

Study Start

July 1, 2013

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

July 19, 2017

Record last verified: 2017-07

Locations